Search research articles
Contact Us
Filters
Showing results (1-10 of 182) with videos related to
Page
of 19
Sort By:
Expert Review of Clinical Immunology
|
October 13, 2025
Toward precision in psoriatic arthritis: addressing the challenge of difficult-to-treat disease
Rubén Queiro, Sara Alonso
Expert Opinion on Biological Therapy
|
April 21, 2026
Step-up or early intensive therapy in psoriatic arthritis: aligning treatment intensity with disease biology
Rubén Queiro, Sara Alonso
Reumatologia Clinica
|
November 26, 2022
Disease impact in axial spondyloarthritis: Divergent roles between family history of disease and HLA-B27?
Sara Alonso, Rubén Queiro
Rheumatology (Oxford, England)
|
August 12, 2020
Family history of disease in spondyloarthritis: a key issue for disease prognosis
Rubén Queiro, Sara Alonso
Discovery Immunology
|
January 5, 2024
Metabolic regulation of γδ intraepithelial lymphocytes
Sara Alonso, Karen Edelblum
Expert Review of Clinical Pharmacology
|
October 17, 2025
Difficult-to-treat psoriatic arthritis: challenges, mechanisms, and future directions
Rubén Queiro, Sara Alonso
Expert Opinion on Pharmacotherapy
|
December 15, 2025
Dual targeting in spondyloarthritis: rethinking cytokine redundancy and the quest for durable remission
Rubén Queiro, Sara Alonso, Mercedes Alperi
Rheumatology (Oxford, England)
|
February 12, 2021
Inflammation-fatigue in spondyloarthritis: a clear link in axial spondyloarthritis but less so in psoriatic arthritis
Rubén Queiro, Sara Alonso, Isla Morante
Expert Review of Clinical Immunology
|
September 29, 2025
Reassessing traditional inflammatory biomarkers in spondyloarthritis: time for a paradigm shift?
Rubén Queiro, Sara Alonso, Mercedes Alperi
Frontiers in Immunology
|
February 27, 2026
Beyond cytokine blockade: could CAR-Tregs open a new era of tissue-targeted immune tolerance in psoriatic arthritis?
Rubén Queiro, Sara Alonso, Mercedes Alperi
Page
of 19
Search research articles
Search
Showing results (1-10 of 182) with videos related to
Sort By:
Page
of 19
Expert Review of Clinical Immunology
|
October 13, 2025
Toward precision in psoriatic arthritis: addressing the challenge of difficult-to-treat disease
Rubén Queiro, Sara Alonso
Expert Opinion on Biological Therapy
|
April 21, 2026
Step-up or early intensive therapy in psoriatic arthritis: aligning treatment intensity with disease biology
Rubén Queiro, Sara Alonso
Reumatologia Clinica
|
November 26, 2022
Disease impact in axial spondyloarthritis: Divergent roles between family history of disease and HLA-B27?
Sara Alonso, Rubén Queiro
Rheumatology (Oxford, England)
|
August 12, 2020
Family history of disease in spondyloarthritis: a key issue for disease prognosis
Rubén Queiro, Sara Alonso
Discovery Immunology
|
January 5, 2024
Metabolic regulation of γδ intraepithelial lymphocytes
Sara Alonso, Karen Edelblum
Expert Review of Clinical Pharmacology
|
October 17, 2025
Difficult-to-treat psoriatic arthritis: challenges, mechanisms, and future directions
Rubén Queiro, Sara Alonso
Expert Opinion on Pharmacotherapy
|
December 15, 2025
Dual targeting in spondyloarthritis: rethinking cytokine redundancy and the quest for durable remission
Rubén Queiro, Sara Alonso, Mercedes Alperi
Rheumatology (Oxford, England)
|
February 12, 2021
Inflammation-fatigue in spondyloarthritis: a clear link in axial spondyloarthritis but less so in psoriatic arthritis
Rubén Queiro, Sara Alonso, Isla Morante
Expert Review of Clinical Immunology
|
September 29, 2025
Reassessing traditional inflammatory biomarkers in spondyloarthritis: time for a paradigm shift?
Rubén Queiro, Sara Alonso, Mercedes Alperi
Frontiers in Immunology
|
February 27, 2026
Beyond cytokine blockade: could CAR-Tregs open a new era of tissue-targeted immune tolerance in psoriatic arthritis?
Rubén Queiro, Sara Alonso, Mercedes Alperi
Page
of 19